| CANDRIAM EQUITIES L BIOTECHNOLOGY R CAP EUR | RVI BIOTECNOLOGÍA | 33,92% | 90,03% | 80,63% | 263,38% |
| AMUNDI MSCI NORTH AMERICA ESG BROAD TRANSITION AU CAP | RVI USA | 15,42% | 67,08% | 65,61% | 263,28% |
| UBS CORE S&P 500 UCITS ETF USD DIS | RVI USA | 15,68% | 67,40% | 68,68% | 263,26% |
| FRANKLIN U.S. OPPORTUNITIES I (ACC) EUR | RVI USA CRECIMIENTO | 4,38% | 51,25% | 22,08% | 263,17% |
| ISHARES CORE S&P 500 UCITS ETF USD (DIST) | RVI USA | 15,79% | 67,56% | 68,66% | 263,13% |
| GOLDMAN SACHS US CORE EQUITY PORTFOLIO R (SNAP) GBP DIS | RVI USA | 12,64% | 67,77% | 67,03% | 263,10% |
| JPM KOREA EQUITY C (ACC) USD | RVI COREA | 42,89% | 128,62% | 82,58% | 262,88% |
| SCHRODER ISF US LARGE CAP C DIS USD | RVI USA | 11,83% | 64,09% | 68,22% | 262,69% |
| SCHRODER ISF TAIWANESE EQUITY B DIS USD | RVI CHINA | 73,82% | 147,90% | 109,12% | 262,62% |
| SCHRODER ISF JAPANESE EQUITY C ACC USD (HEDGED) | RVI JAPÓN | 25,78% | 70,44% | 111,89% | 262,45% |
